Ivermectin for Horses: Uses, Safety, and Resistance

Ivermectin remains one of the most widely used dewormers in horses, effective against a broad range of internal parasites including large and small strongyles, roundworms, pinworms, bots, and the microfilariae of neck threadworms. A single oral dose at 0.2 mg per kilogram of body weight removes roughly 95% or more of the common nematode and bot species that infect horses naturally. But the landscape around equine ivermectin use has shifted considerably since the drug’s introduction in the early 1980s, and horse owners relying on it today face questions about resistance, timing, environmental effects, and when a different drug might be the better choice.

How Ivermectin Kills Parasites

Ivermectin belongs to the macrocyclic lactone class of drugs. It works by binding to specific chloride channel receptors found in the nerve and muscle cells of invertebrates. When the drug locks onto these receptors, chloride ions flood into the cells, which paralyzes the parasite’s pharynx (the structure it uses to feed) and its body-wall muscles. The worm essentially starves or suffocates because it can no longer pump food or move through the gut. Mammals, including horses, do not have these same chloride channels accessible to the drug under normal circumstances, which is why ivermectin is safe for horses at labeled doses but lethal to the worms inside them.¹

What It Covers

Early trials in naturally infected horses demonstrated that ivermectin handles an impressively wide list of equine parasites. The large strongyles, including the particularly dangerous Strongylus vulgaris, were effectively cleared at doses as low as 0.02 mg/kg. Adult small strongyles (cyathostomins), fourth-stage cyathostome larvae still in the gut lumen, fourth-stage pinworms, fifth-stage ascarids, Onchocerca cervicalis microfilariae, and stomach bots (Gasterophilus intestinalis and G. nasalis) were all significantly reduced or eliminated at 0.1–0.2 mg/kg.²

One historically important use has been against migrating S. vulgaris larvae, which burrow into the walls of the horse’s mesenteric arteries and cause a condition called verminous arteritis. Even late-stage larvae lodged near the origins of major intestinal arteries were eliminated with about 99% effectiveness, and follow-up imaging showed the arterial lesions regressing after treatment.³ Before ivermectin, S. vulgaris was a leading cause of colic and sudden death in horses. The drug’s ability to reach migrating larvae, not just adults sitting in the gut, was a genuine breakthrough.

Where ivermectin falls short is against encysted small strongyle larvae. Cyathostomins have a life-stage trick: early third-stage larvae can burrow into the wall of the large intestine and enter a dormant (hypobiotic) state, sometimes for months. Ivermectin has essentially zero activity against these encysted stages, whether the larvae are in early or late dormancy.⁴ This means ivermectin kills what is in the gut lumen but leaves a reservoir of larvae embedded in the intestinal wall, ready to emerge later.

Oral Paste Versus Other Routes

The standard way to give ivermectin to horses is an oral paste syringe, dosed at 0.2 mg/kg. This is the formulation most horse owners are familiar with, and for good reason: it works. But how you deliver ivermectin matters more than you might expect. When pregnant mares were given ivermectin as a liquid by stomach tube versus the standard paste, the liquid reached higher peak blood levels faster and delivered more total drug into the bloodstream.⁵ In everyday practice, though, the paste is preferred because it does not require a veterinarian to pass a tube.

Some horse owners have been tempted to use cattle pour-on formulations of ivermectin on horses, since they are cheaper. Research shows this is a bad idea. When a bovine pour-on product was applied topically to horses at 0.5 mg/kg (more than double the oral dose), the drug reached lower blood concentrations and reduced parasite egg counts less effectively than oral paste at the standard 0.2 mg/kg dose. The oral paste reduced fecal egg counts by over 95% for ten weeks, while the pour-on group fluctuated between 82% and 97% reduction.⁶ In short, pour-on formulations are not designed for equine skin and do not deliver the drug reliably.

The Resistance Problem

For decades, ivermectin was considered nearly bulletproof against equine parasites. That reputation is now fraying. Resistance has emerged in two important parasite groups, and the pattern differs between them.

The first and most alarming case involves Parascaris species, the large roundworm that primarily affects foals. Ivermectin resistance in Parascaris has been documented on multiple continents. A Swedish study found that ivermectin showed little or no activity against ascarid eggs on five out of six farms tested, while older drugs like fenbendazole and pyrantel still achieved greater than 90% reduction.⁷ A Polish survey similarly found Parascaris eggs in about 28% of foals after ivermectin treatment, with average efficacy of only 49%.⁸ For foals with heavy roundworm burdens, this is not a theoretical problem. A large Parascaris burden can cause intestinal blockage and death, and using a drug that no longer works wastes critical time.

The second concern involves cyathostomins, the small strongyles that are now the most common and economically significant intestinal parasite of adult horses. An Argentine study found ivermectin efficacy against cyathostomins of only about 79% at two weeks post-treatment and roughly 69% at 19 days, well below the threshold for adequate performance.⁹ Meanwhile, a Danish study using an automated egg-counting system flagged ivermectin resistance in six equine operations and inconclusive results in another eight, though traditional manual counting methods found fewer problems in the same populations.¹⁰ That discrepancy matters: it suggests resistance may be creeping in before standard testing methods catch it.

Not all regions see the same picture. A German survey of 42 horse farms found that ivermectin still achieved 100% egg-count reduction on 37 of them, with the remaining five farms showing reductions between roughly 98% and 100%.¹¹ And a mid-Atlantic U.S. study found that macrocyclic lactones including ivermectin showed high efficacy across all horses sampled.¹² So ivermectin is not failing everywhere, but the direction of travel is clear: resistance is spreading, and it is no longer safe to assume the drug will work on every farm.

How Resistance Develops

Research points to cellular pumps called P-glycoproteins as one mechanism worms use to resist macrocyclic lactones like ivermectin. These are transport proteins that sit in the cell membrane and actively pump foreign chemicals back out. When worm populations are exposed to ivermectin repeatedly, individuals that overexpress these pumps survive and reproduce, shifting the population toward resistance over time. Genetic studies have shown an association between drug selection pressure and changes in these transporter genes, and experimentally blocking the pump proteins can restore drug sensitivity in resistant worm populations.¹³ Work specifically in cyathostomins has confirmed that P-glycoproteins play a role in ivermectin resistance in these horse parasites.¹⁴

The practical takeaway is that every unnecessary treatment accelerates the selection pressure. Horses that do not need deworming are still getting dewormed on many farms, and each of those treatments pushes the worm population a step closer to resistance.

Fecal Egg Counts and Targeted Treatment

The American Association of Equine Practitioners recommends an evidence-based approach to deworming rather than treating every horse on a fixed calendar. The cornerstone of this strategy is the fecal egg count (FEC), a simple test where a manure sample is examined under a microscope to estimate the number of parasite eggs per gram. Horses shedding more than 500 eggs per gram are treated; those below 200 eggs per gram are typically left alone. Roughly 50–75% of adult horses in any given herd fall into the low-shedder category, meaning they do not need treatment at all during a given cycle.¹⁵

Despite this recommendation, many horse owners still deworm on a rigid schedule, treating all animals whether they need it or not.¹⁶ This approach is not just wasteful; it is actively harmful, because it exposes the parasite population on the farm to maximum selection pressure. Every horse treated unnecessarily gives resistant worms a competitive advantage. Leaving the low shedders untreated preserves a population of drug-susceptible worms on the pasture, which dilutes the resistant genes and slows the spread of resistance.

Reassuringly, research on what happens after selective ivermectin treatment shows that parasite diversity is maintained. When horses were treated based on FEC results and then monitored at egg reappearance, the range of cyathostomin species and their diversity did not differ detectably from what was present before treatment.¹⁷ The selective approach does not wipe out species diversity in the worm population, which is a sign that the parasite community is being managed sustainably rather than driven into a resistant bottleneck.

Adverse Reactions and Safety

Ivermectin has a wide safety margin in horses at the labeled dose. The most commonly discussed side effect is a transient swelling on the belly or along the midline, which occurs in some horses as the drug kills Onchocerca cervicalis microfilariae in the skin. In one study, about 10% of treated horses developed edema on the lower abdomen, and 15% developed swelling within the area of existing skin lesions. These reactions resolved within one to three days, whether or not corticosteroids were given.¹⁸ The reaction is caused by the dying parasites in the skin, not by the drug itself, and is more of an annoyance than a danger.

True toxicosis from ivermectin overdose is rare in horses but has been documented in very young foals. A case report described a four-day-old thoroughbred colt that developed severe neurologic signs after accidental overdose. The foal was treated with intravenous lipid emulsion, which binds the fat-soluble drug and pulls it out of nerve tissue, and recovered completely without complications.¹⁹ Neonatal foals have an immature blood-brain barrier, which makes them more vulnerable. Most veterinarians advise waiting until a foal is at least several weeks old before administering any ivermectin product.

Ivermectin Versus Moxidectin

Moxidectin is the other macrocyclic lactone licensed for horses, and in several respects it fills gaps that ivermectin cannot. Both drugs achieve about 99% efficacy against adult cyathostomins and large strongyles in the gut lumen. But moxidectin has moderate efficacy (roughly 63–79%) against encysted late-stage cyathostomin larvae, while ivermectin is completely ineffective against these stages. On the other hand, ivermectin is far superior against stomach bots, achieving about 95% kill against third-instar Gasterophilus, compared to moxidectin’s poor showing of 0–20%.²⁰

Moxidectin also has a longer duration of activity. It distributes more broadly into fat tissue and has a longer half-life, which translates into a longer egg reappearance period after treatment.²¹ A Canadian field study comparing the two drugs over winter found that while both reduced strongyle egg counts to zero at three weeks, by five months post-treatment the horses treated with ivermectin had significantly higher egg counts than those treated with moxidectin.²² For horse owners who need longer intervals between treatments, moxidectin has an edge.

Neither drug alone covers everything. A practical approach many veterinarians use is to alternate strategically: ivermectin during bot season (typically late fall in temperate climates) to address bots, and moxidectin at other times when encysted cyathostomins are the bigger concern. The choice should be guided by fecal egg counts and regional resistance patterns rather than a one-size-fits-all rotation.

Combination Products

One persistent gap in ivermectin’s spectrum is tapeworms. Ivermectin has no activity against equine tapeworms (Anoplocephala perfoliata), which can cause ileocecal colic. To address this, combination products pairing ivermectin with praziquantel have been developed. Praziquantel is the standard tapeworm drug in veterinary medicine, and combining it with ivermectin in a single oral paste lets you treat nematodes, bots, and cestodes in one dose.²³

Field testing of this combination in Thoroughbred yearlings showed strongyle egg-count reductions over 90% at two weeks post-treatment, with counts starting to climb back around four weeks. Tapeworm efficacy hit 96% at two weeks and held for the entire ten-week monitoring period.²⁴ If your veterinarian suspects tapeworm exposure, a combination product or separate praziquantel treatment is the only way to cover that parasite; ivermectin alone will not touch it.

Environmental Costs of Ivermectin Use

Something horse owners rarely think about is what happens after the drug leaves the horse. Ivermectin is excreted in manure, often still in its active form or as toxic metabolites. Those chemicals enter the pasture environment through dung pats, where they affect insects that colonize and break down horse manure. Of the commonly used equine dewormers, ivermectin is the most ecotoxic. It is harmful to dung beetles, earthworms, and some aquatic organisms. By comparison, moxidectin appears to be less toxic to dung fauna, and fenbendazole seems to have little impact on dung-colonizing insects, though it may be toxic to aquatic organisms and fungi.²⁵

Dung beetles matter because they break apart manure pats, aerating the soil and reducing the larval habitat for parasites. Killing off dung beetles with ivermectin-laden manure is counterproductive in the long run: you remove the natural biological control that helps keep pasture contamination down. One more reason to avoid treating horses that do not need deworming, and to pick up manure from paddocks where ivermectin has recently been administered.

Donkeys and Mules Are Not Just Small Horses

If you keep donkeys or mules alongside horses, be aware that drug metabolism differs significantly among equids. Donkeys and mules tend to clear drugs faster than horses. Studies have found that donkeys have greater drug-elimination capacity, and mules may require substantially higher doses of certain drugs to achieve the same effect as in horses. Research on xylazine (a sedative) showed a significant difference in half-life between horses and mules, with mules sometimes needing up to 50% more drug.²⁶ This faster clearance means that using the same ivermectin dose calculated for a horse may result in lower blood levels and potentially less effective deworming in a donkey or mule. If you manage a mixed herd, working with a veterinarian who understands these metabolic differences is worth the effort.